Atlas Trials

Study on the Performance and Safety of Sentinox in COVID-19 Patients

Clinical trial NCT04909996 · COMPLETED

Trial details

NCT number
NCT04909996
Sponsor
APR Applied Pharma Research s.a.
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
COVID-19 (SARS-CoV-2 Infection)
Start date
2021-05-20
Primary completion
2021-11-30
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.